The largest database of trusted experimental protocols

582 protocols using mmessage mmachine kit

1

Transcription of RASSF1A and Tubulin K40Q

Check if the same lab product or an alternative is used in the 5 most similar protocols
The RASSF1A and tubulin K40Q clones were obtained from Addgene (RASSF1A, #37016; tubulin K40Q, #32912). The full-length cDNA sequence encoding RASSF1A was subcloned into pRN3-mCherry vector and in vitro transcribed using a mMessage mMachine kit (Ambion). tubulin K40Q clone was directly in vitro transcribed and polyadenylated using mMessage mMachine kit and poly(A) tailing kit (Ambion), respectively.
+ Open protocol
+ Expand
2

Genetic Manipulation in Zebrafish Embryos

Check if the same lab product or an alternative is used in the 5 most similar protocols
Capped mRNA encoding tol2 transposase was transcribed from the pCS2-FA vector (Dr Michael Pack, University of Pennsylvania, USA) using the mMessage mMachine kit (Ambion) and approximately 1 nl of a mix of 10 ng/μl pT2KXIGDin-enpep vector containing OCRL1a, 10 ng/μl cmcl2:GFP vector and 20 ng/μl tol2 transposase mRNA was injected into one-cell stage mutant embryos. mApple-Rab11a capped mRNA was transcribed using the mMessage mMachine kit (Ambion) and 1 nl of 200 ng/μl was injected into one-cell stage embryos. Morpholinos were obtained from GeneTools. Control and OCRL1 Morpholinos were injected as described previously [31 (link)]. Morpholino targeting zebrafish PIP5Kαb (ENSDARG00000024642—splice blocking MO: TGCGTGTTATATCTAACAGATAGTC) was injected at 2 ng into one cell stage embryos. The IFT88/Polaris splice blocking MO was described previously [34 (link)].
+ Open protocol
+ Expand
3

Microinjection of Anti-sfSGK-HM Antibody

Check if the same lab product or an alternative is used in the 5 most similar protocols
Microinjection was performed as previously described (Kishimoto, 1986 (link); Chiba et al., 1992 (link)). The anti-sfSGK-HM antibody or control IgG was injected into unstimulated oocytes at 23°C at a final concentration in the oocytes of 65.2 µg/ml, followed by incubation for 1 h. For expression of the mutant sfSGK constructs (T479E and K183M/T479E), mRNAs encoding each mutant were transcribed from the pSP64-S–based vector construct and subsequently polyadenylated at their 3′ termini using the mMESSAGE mMACHINE kit and the Poly(A) Tailing Kit (Thermo Fisher Scientific). They were then dissolved in water and injected into unstimulated oocytes (15 pg per oocyte). After further incubation for 22 h at 20°C, these oocytes were treated with 0.5 µM 1-MA and recovered for immunoblotting analysis. The rest of the oocytes were observed to count GVBD.
+ Open protocol
+ Expand
4

Xenopus Embryo Manipulation and Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Xenopus embryos were generated and cultured according to general protocols and staged according to the normal table of Nieuwkoop and Faber [55 ]. All procedures were performed according to the German animal use and care law (Tierschutzgesetz) and approved by the local authorities and committees (animal care and housing approval: I/39/EE006, Veterinäramt Erlangen; animal experiments approval: 54–2532.2–8/08, German state administration Bavaria/Regierung von Mittelfranken).
RNA for microinjection was prepared using the mMessage mMachine Kit (ThermoFisher Scientific, USA). The following amounts were injected: 500 pg for alk3–5′-gfp and alk6–5′-gfp, 50 pg of alk3-flag and alk6-flag RNA; 25 pg of pCS2 alk3-flag and pCS2 alk6-flag DNA and 100 pg of pCS2-β-galactosidase DNA. Knock-down was achieved by injection of 0.8 pmol or 1.6 pmol of ALK3 MO and ALK6 MO as indicated.
Embryos were injected and cultured until they reached the desired stage as indicated.
For subsequent in situ hybridization, single side injections were performed and traced by co-injection of pCS2-β-galactosidase DNA. The injected side was visualized by ß-galactosidase staining and in situ hybridizations were carried out, as described by Harland [104 (link)], using chordin [77 (link)], sox2 [105 (link)], twist [106 (link)], msx2, alk3, alk6 or bmpr2 as antisense probes, respectively.
+ Open protocol
+ Expand
5

Transcription Factors in Neural Development

Check if the same lab product or an alternative is used in the 5 most similar protocols
5′capped and polyadenylated mRNAs encoding TFs expressed by cells in the neural plate (foxd4l1.1; Sullivan et al., 2001 (link)), neural crest (foxd3, Sasai et al., 2001 (link); msx1, Suzuki et al., 1997 (link); Tribulo et al., 2003 (link); Monsoro-Burq et al., 2005 (link); zic1, zic2, and zic3, Nakata et al., 1997 (link), Nakata et al., 1998 (link)), PPR (six1;Brugmann et al., 2004 (link)), or epidermis (dlx5, Papalopulu and Kintner, 1993 (link); Luo et al., 2001 (link)), as well as a nucleus-localized β-galactosidase (nβgal) as a lineage tracer, were synthesized in vitro (mMessage mMachine kit, ThermoFisher). Antisense RNA probes for in situ hybridization (ISH) were synthesized in vitro (MEGAscript kit; ThermoFisher) as previously described (Yan et al., 2009 (link)).
+ Open protocol
+ Expand
6

Generating Tardbp and Tardbpl Knockout Zebrafish

Check if the same lab product or an alternative is used in the 5 most similar protocols
For the generation of tardbp and tardbpl knockout fish, target sequences for Cas9-mediated cleavage were searched by CRISPRscan63 (link). The target sequences CAAGACTTAAAAGACTACTTcgg and CAAGACTTAAAAGACTACTTcgg, where the protospacer adjacent motifs (PAMs) are indicated by lower cases, were chosen for the generation of tardbp-n115 and tardbpl-n94 alleles, respectively. hSpCas9 was in vitro-transcribed with mMESSAGE mMACHINE Kit (Thermo Fisher Scientific, AM1340) by using pCS2 + hSpCas9 plasmid as a template (a gift from Masato Kinoshita, Addgene plasmid # 51815). Wild type embryos were injected with 25 pg of sgRNA and 300 pg of hSpCas9 mRNA at the one-cell stage.
+ Open protocol
+ Expand
7

Generating Chimeric Ion Channels

Check if the same lab product or an alternative is used in the 5 most similar protocols
Channel chimeras were generated using sequential PCR with KV2.1Δ747 (link),48 (link) (Genscript, USA) and hNaV1.6 (NM_014191, Origene Technologies, USA) as templates. cRNA was synthesized using T7 polymerase (mMessage mMachine kit, Thermo Fisher, USA) after linearizing cDNA with appropriate restriction enzymes. This chimeric approach was previously shown to robustly indicate the binding locus of toxins32 (link). Boundaries of the chimeras were chosen as reported previously in Fig. S2 of Bosmans et al. 201133 (link) and include the transfer of hNaV1.6 regions (MMAYITEFVNLGNVSALRTFRVLR (VSDI), GFIVSLSLMELSLADVEGLSVLRSFRLLR (VSDII), SLVSLIANALGYSELGAIKSLRTLRALR (VSDIII), SIVGMFLADIIEKYFVSPTLFRVIRLARIGRILR (VSDIV) into KV2.1.
+ Open protocol
+ Expand
8

Infectious cDNA Clone Production

Check if the same lab product or an alternative is used in the 5 most similar protocols
The infectious cDNA clone was linearized by SacI (New England Biolabs) digestion, followed by phenol/chloroform extractions. The linearized templates were in vitro transcribed with mMESSAGE mMACHINE kit from ThermoFisher Scientific (Waltham, Massachusetts, USA); and the viral RNAs thus obtained were electroporated in BHK21 (ATCC CCL-10) cells. The viral supernatants were harvested after 48 h and used to infect new BHK21 cells and constitute a stock for the experiments. All the viral stocks produced were titrated by plaque assay on Vero cells [33 (link)].
+ Open protocol
+ Expand
9

Heterologous Expression of KCNE and KCNQ Channels

Check if the same lab product or an alternative is used in the 5 most similar protocols
As previously described7 (link), we generated cRNA transcripts encoding human KCNE1, KCNE3, KCNQ1, KCNQ2, KCNQ3, KCNQ4 or KCNQ5 by in vitro transcription using the mMessage mMachine kit (Thermo Fisher Scientific), after vector linearization, from cDNA sub-cloned into plasmids incorporating Xenopus laevis β-globin 5′ and 3′ UTRs flanking the coding region to enhance translation and cRNA stability. We generated mutant KCNQ1, KCNQ2 and KCNQ3 cDNAs by site-directed mutagenesis with a QuikChange kit (Stratagene, San Diego, CA) and prepared the cRNAs as above. We injected defolliculated stage V and VI Xenopus laevis oocytes (Xenoocyte, Dexter, MI, US and NASCO, Fort Atkinson, WI, US) with KCNE and/or KCNQ cRNAs (2–20 ng). We incubated the oocytes at 16 °C in ND96 oocyte storage solution containing penicillin and streptomycin, with daily washing, for 2–4 days prior to TEVC recording.
+ Open protocol
+ Expand
10

Synthesis of Capped and Uncapped RNA

Check if the same lab product or an alternative is used in the 5 most similar protocols
PCR reactions were performed with DreamTaq (Thermo Fisher) in 50 μL reaction volume using 10 ng of a pYes plasmid construct as a template, 0.4 μM forward (5′-CGGATCGGACTACTAGCAGCTG -3′) and 0.4 μM reverse (5′-TTCATTAATGCAGGGCCGCAAATT-3′) primers that anneal upstream and downstream of the PT7 and the TERCYC1 elements, respectively. PCR products were purified and concentrated using type D4004 ZYMO column (ZYMO Research) and DNA concentrations were estimated spectrophotometrically. To synthetize uncapped RNA, 1 μg of PCR-generated DNA template was transcribed in the T7-polymerase reaction using TranscriptAid T7 High Yield Transcription kit (Thermo Scientific) according to the manufacturer's recommendations. Reaction mixtures were incubated for 120 min at 37 °C, followed by DNase treatment for 15 min at 37 °C. RNA transcripts were first purified by phenol/chloroform extraction, followed by EtOH precipitation; pellets were resuspended in 50 μL of H2O and separated from unincorporated nucleotides by gel filtration on Micro Bio-Spin P-30 columns (Bio-Rad). RNA was aliquoted and stored at − 80 °C.
To generate capped RNA, purified PCR products (described above) were used as DNA templates in coupled T7 RNA polymerization–RNA capping reactions (mMESSAGE mMACHINE kit, Thermo Fisher #AM1344M), incubated for 1 h at 37 °C.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!